Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ala-beta-nal-ala-trp-phe-lys-nh2
2. Alanyl-(2-naphthyl)alanyl-alanyl-tryptophyl-phenylalanyl-lysinamide
3. D-alanyl-3-(2-naphthyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide
4. Ghrp-2
5. Growth Hormone-releasing Peptide-2
6. Kp 102
7. Kp-102
1. 158861-67-7
2. Ghrp-2
3. Kp-102
4. Pralmorelin (free Base)
5. Pralmorelin [inn]
6. D-alanyl-3-(2-naphthalenyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide
7. L-lysinamide, D-alanyl-3-(2-naphthalenyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-
8. E6s6e1f19m
9. Growth Hormone-releasing Peptide 2
10. Kp 102
11. (2s)-6-amino-2-[[(2r)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-[[(2r)-2-aminopropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
12. (s)-2-((2r,5s,8s,11r,14r)-5-((1h-indol-3-yl)methyl)-14-amino-2-benzyl-8-methyl-11-(naphthalen-2-ylmethyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecanamido)-6-aminohexanamide
13. Way-gpa-748
14. D-alanyl-3-(2-naphthyl)-d-alanyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide
15. Kp-102d
16. Ghrp Kaken 100
17. Pralmorelin [mi]
18. Ghrp 2
19. Unii-e6s6e1f19m
20. Pralmorelin [who-dd]
21. Schembl424791
22. Chembl106593
23. Gtpl1092
24. Kp-102ln
25. Gpa-748
26. Kp-102t
27. Chebi:135890
28. Dtxsid601032404
29. Growth Hormone Releasing Peptide 2
30. Growth Hormone Releasing Peptide-2
31. Growth Hormone-releasing Peptide-2
32. Ex-a5533
33. Ala-beta-nal-ala-trp-phe-lys-nh2
34. Mfcd00674876
35. Zinc85537068
36. Akos037652421
37. D-ala-d-2-nal-ala-trp-d-phe-lys-nh2
38. Ds-3435
39. Ft-0656752
40. C73002
41. 861p677
42. Pralmorelin Trifluoroacetate Salt, >=97% (hplc)
43. Q21098924
44. D-ala-3-(2-naphthyl)-d-ala-ala-trp-d-phe-lys-nh2
45. Alanyl-(2-naphthyl)alanyl-alanyl-tryptophyl-phenylalanyl-lysinamide
Molecular Weight | 818.0 g/mol |
---|---|
Molecular Formula | C45H55N9O6 |
XLogP3 | 2.5 |
Hydrogen Bond Donor Count | 9 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 21 |
Exact Mass | 817.42753051 g/mol |
Monoisotopic Mass | 817.42753051 g/mol |
Topological Polar Surface Area | 256 Ų |
Heavy Atom Count | 60 |
Formal Charge | 0 |
Complexity | 1440 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Growth Substances
Signal molecules that are involved in the control of cell growth and differentiation. (See all compounds classified as Growth Substances.)
ABOUT THIS PAGE
A Pralmorelin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pralmorelin, including repackagers and relabelers. The FDA regulates Pralmorelin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pralmorelin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pralmorelin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pralmorelin supplier is an individual or a company that provides Pralmorelin active pharmaceutical ingredient (API) or Pralmorelin finished formulations upon request. The Pralmorelin suppliers may include Pralmorelin API manufacturers, exporters, distributors and traders.
click here to find a list of Pralmorelin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pralmorelin DMF (Drug Master File) is a document detailing the whole manufacturing process of Pralmorelin active pharmaceutical ingredient (API) in detail. Different forms of Pralmorelin DMFs exist exist since differing nations have different regulations, such as Pralmorelin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pralmorelin DMF submitted to regulatory agencies in the US is known as a USDMF. Pralmorelin USDMF includes data on Pralmorelin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pralmorelin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pralmorelin suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pralmorelin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pralmorelin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pralmorelin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pralmorelin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pralmorelin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pralmorelin suppliers with NDC on PharmaCompass.
Pralmorelin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pralmorelin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pralmorelin GMP manufacturer or Pralmorelin GMP API supplier for your needs.
A Pralmorelin CoA (Certificate of Analysis) is a formal document that attests to Pralmorelin's compliance with Pralmorelin specifications and serves as a tool for batch-level quality control.
Pralmorelin CoA mostly includes findings from lab analyses of a specific batch. For each Pralmorelin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pralmorelin may be tested according to a variety of international standards, such as European Pharmacopoeia (Pralmorelin EP), Pralmorelin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pralmorelin USP).
LOOKING FOR A SUPPLIER?